IL2 and graft versus host disease: Different approaches have been attempted for the use of Treg cells in prevention or treatment of acute and chronic GVHD, including the adoptive transfer of Treg cells from different donor sources [22, 49] or enhancement of in vivo Treg function by administration of low doses of IL-2 [50].